Skip to main content
. 2024 Nov 5;30(11):e70109. doi: 10.1111/cns.70109

FIGURE 2.

FIGURE 2

There were no correlations between MPO activity and XDP clinical parameters. There was no impact of (A) age at disease onset (Spearman correlation, r = 0.05046, p = 0.8107), (B) age at death (Spearman correlation, r = 0.09327, p = 0.6574), (C) disease duration (in months) (Spearman correlation, r = 0.1537, p = 0.4633), and (D) repeat size within the SVA (Spearman correlation, r = 0.09051, p = 0.6670) on MPO activity in XDP PFC (n = 25).